Animal Vaccine FAQs: Protecting Pets, Livestock and Wildlife
Vaccination is a cornerstone of preventive health care and one of the most effective ways to maintain an animal’s health and quality of life. Vaccines prevent animal suffering and death from infectious diseases, support the conservation of biodiversity and strengthen global food and economic security. It is estimated that more than are zoonotic and can spread from animals to people, highlighting an inextricable link between human and animal health.
Human and animal health have always been closely intertwined. In fact, the word “vaccine” was derived from vacca, the Latin word for cow, in reference to the first successful vaccine, which protected people from smallpox and was made from the cowpox virus by .
This FAQ outlines questions about veterinary vaccines and their role in protecting the health of animals, people and the planet.
Veterinary Vaccines: The Basics
Why Is Vaccinating Animals Important?
Vaccines protect pets, livestock and wildlife from life-threatening diseases. For pet owners, this means fewer medical emergencies and healthier companions. For farmers, vaccinating livestock protects entire herds and flocks, safeguarding food supplies and preserving family livelihoods. On a public health level, vaccinating animals decreases the risk of zoonotic diseases transmitted from animals to humans. It also reduces the need for antibiotic treatments, which prevents increasing antimicrobial resistance in animals and people.
How Does Animal Vaccination Work?
Just like in humans, vaccines train an animal’s immune system to recognize and fight disease. Vaccines introduce a small, safe piece of a disease-causing organism into an animal’s body (also called an antigen). The immune system then recognizes the antigen as a threat and triggers an immune response, including activating immune cells and antibody production. This response builds memory in the body for how to respond should the host come in contact with the pathogen in the future. When enough animals in a population are vaccinated, the spread of disease can slow or, potentially, stop altogether.
How Are Veterinary Vaccines Tested for Safety and Effectiveness?
Veterinary vaccines go through years of careful research and testing before they are available for use. On average, the development process takes , depending on the country, technology and target species. National —such as the in the U.S. or the in the European Union—set strict guidelines and require laboratory studies, safety trials and field testing to confirm safety and effectiveness. After approval, vaccines continue to be monitored for adverse side effects, which are rare, generally occurring in . Mild symptoms, like , are more common and indicative that the vaccine is taking effect. These side effects usually go away within 24 hours.
What Types of Vaccines Are Used in Animals?
Most licensed veterinary vaccines today are:
- Live-attenuated: a vaccine containing an intact but weakened (or attenuated) pathogen, which stimulates an immune response but does not cause disease. Because these vaccines introduce an intact microorganism that is most similar to the natural pathogen they are immunizing against, live-attenuated vaccines create a strong and long-lasting immune response and usually require only 1 injection. Examples include vaccines to protect cattle against and all vaccines.
- Inactivated: a vaccine containing a killed (or inactivated) pathogen that is no longer infectious. These vaccines usually don’t provide as much protection as live vaccines, so to maximize their effectiveness. Examples include the , and most .
- Toxoid: a vaccine that uses an inactivated toxin produced by a pathogen. These vaccines stimulate immunity and protect the animal against toxins such as , caused by Clostridium tetani. They are often administered in horses as well as sheep, goats and cattle.
- Recombinant: a vaccine made by inserting DNA encoding an antigen, such as a bacterial surface protein, into another source (often a plasmid expressed in yeast or bacteria). These microbial cells produce the antigen in large quantities, which is then purified for use as the vaccine. Once administered, the purified antigens stimulate the production of antibodies specific to the vaccine antigen. Because of their targeted design, recombinant vaccines than other vaccine types. Often, they also require . Examples include the vaccine for , the leading cause of virus-associated deaths in cats.
Looking ahead, mRNA vaccines, which produce proteins to trigger an immune response, are . They can be developed rapidly, target specific pathogens, be adapted to emerging variants and stimulate strong immune responses in animals. , a vaccine that utilizes the neuraminidase (NA) protein to vaccinate pigs against influenza strains H1N1, H1N2 and H3N2, was launched in 2024 in the U.S. Additionally, Merck Animal Health announced the release of , the first and only mRNA vaccine that safeguards dogs against the threat of canine flu, and , the only non-adjuvanted FeLV vaccine built on RNA particle technology. Despite this promising outlook, shifts in U.S. could slow the pace of veterinary mRNA vaccine development.
What Barriers Do Owners Face When It Comes to Vaccinating Their Animals?
Despite being one of the most effective tools to prevent disease, animal vaccines remain underutilized. Several factors contribute to this gap. In many rural or low-income areas, especially among livestock farmers, . Financial barriers are another hurdle—pet vaccines are typically paid out-of-pocket, and pet insurance is not widely used. In the U.K., cite cost as the reason for skipping vaccines. For smaller-scale farms, competing expenses can make preventive care feel less urgent, even though it protects long-term livelihoods.
Infrastructure also matters: in countries that lack strong animal health systems and have few government veterinarians and limited surveillance capacity, it can be . Access to veterinary care and vaccination services can be , and and misinformation may discourage owners from vaccinating at all. Improving uptake requires a , including vaccine education, fostering public–private partnerships to build stronger infrastructure and offering subsidies or incentives for priority and repeat vaccinations.
In This Issue
- The Link Between Pets, People and Antimicrobial Resistance
- Shedding Light on the Vibrio-Squid Symbiosis
- Baiting Mice to Beat Lyme Disease
- Skin Deep: How Bd and Bsal Fungi Threaten Amphibian Health
- Food Biosecurity: Flyways, Flocks, CAFOs and Avian Flu
- How FMTs, Coprophagia and the Milk Microbiome Inform Wildlife Conservation With Sally Bornbusch
- Animal Vaccine FAQs: Protecting Pets, Livestock and Wildlife
- New World Screwworm: Rise, Fall and Resurgence
- Is a Future Without Animal Models Possible?